Cite
HARVARD Citation
Sulzmaier, F. et al. (2023). INBRX-120, a CD8α-targeted detuned IL-2 that selectively expands and activates tumoricidal effector cells for safe and durable in vivo responses. Journal for immunotherapy of cancer. 11 (1), p. . [Online].